Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson's Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial

Peterschmitt, M. Judith; Saiki, Hidemoto; Hatano, Taku; Gasser, Thomas; Isaacson, Stuart H.; Gaemers, Sebastiaan J. M.; Minini, Pascal; Saubadu, Stephane; Sharma, Jyoti; Walbillic, Samantha; Alcalay, Roy N.; Cutter, Gary; Hattori, Nobutaka; Hoeglinger, Gunter U.; Marek, Kenneth; Schapira, Anthony H., V; Scherzer, Clemens R.; Simuni, Tanya; Giladi, Nir; Sardi, Sergio Pablo; Fischer, Tanya Z.

Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson's Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial

Autor(en):

Peterschmitt, M. Judith; Saiki, Hidemoto; Hatano, Taku; Gasser, Thomas; Isaacson, Stuart H.; Gaemers, Sebastiaan J. M.; Minini, Pascal; Saubadu, Stephane; Sharma, Jyoti; Walbillic, Samantha; Alcalay, Roy N.; Cutter, Gary; Hattori, Nobutaka; Hoeglinger, Gunter U.; Marek, Kenneth; Schapira, Anthony H., V; Scherzer, Clemens R.; Simuni, Tanya; Giladi, Nir; Sardi, Sergio Pablo; Fischer, Tanya Z.

Tübinger Autor(en):

Gasser, Thomas

Erschienen in:

Journal of Parkinsons Disease (2022), Bd. 12, H. 2, S. 557-570

Verlagsangabe:

Ios Press

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.3233/JPD-212714

ISSN:

1877-7171